West China Second University Hospital
Clinical trials sponsored by West China Second University Hospital, explained in plain language.
-
New drug HS-10518 put to the test in healthy volunteers
Knowledge-focused CompletedThis early-stage study tested the safety and tolerability of a new drug called HS-10518 in 60 healthy premenopausal women in China. Participants received either the drug or a placebo, and researchers monitored for side effects and how the drug moved through the body. The goal was…
Phase: PHASE1 • Sponsor: West China Second University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Healthy volunteers test new Ginkgo-Based injection for safety
Knowledge-focused CompletedThis early-stage study tested the safety and tolerability of Ginkgolide B injection in 36 healthy adults aged 18 to 45. Participants received single or multiple doses to see how the drug behaves in the body and what side effects occur. The goal was to gather safety data, not to t…
Phase: PHASE1 • Sponsor: West China Second University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
New Slow-Release pill for muscle disease tested in healthy volunteers
Knowledge-focused CompletedThis study tested a new sustained-release (long-acting) version of pyridostigmine, a drug used for myasthenia gravis (a muscle weakness disease). Forty healthy Chinese adults took both the new long-acting tablet and the standard immediate-release tablet at different times to comp…
Phase: PHASE1 • Sponsor: West China Second University Hospital • Aim: Knowledge-focused
Last updated Jun 26, 2026 13:53 UTC